Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-20
1999-03-09
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546210, A61K 31005, C07D40112
Patent
active
058801383
ABSTRACT:
This invention discloses novel piperidine tetrazole compounds which are selective antagonists of EAA receptors particularly the NMDA receptors. The invention also provides formulations of the preferred compounds and for methods of using the compounds to treat various disorders associated with neuronal excitotoxicity.
REFERENCES:
patent: 4902687 (1990-02-01), Ornstein
patent: 4968678 (1990-11-01), Ornstein
patent: 5192751 (1993-03-01), Thor
patent: 5331001 (1994-07-01), Hamilton
Ornstein, et al., J. Med. Chem. (1991), 34, pp. 90-97.
Ornstein, et al., J. Med. Chem. (1992), 35, pp. 3111-3115.
Ornstein, et al., J. Med. Chem. (1992), 35, pp. 3547-3560.
Yoshiyama, et al., Br. J. Pharmacol. (1993), 110, pp. 77-86.
Schoepp, et al., Eur. J. Pharmacol. (1990), 182(3), pp. 421-427.
Heinz Lawrence J.
Lunn William H. W.
Ornstein Paul L.
Chang Ceila
Eli Lilly and Company
Lentz Nelsen L.
LandOfFree
NMDA receptor selective antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NMDA receptor selective antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NMDA receptor selective antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321433